Quanterix Slashes 2026 Revenue Outlook by 15%, Delays Breakeven
QTRX is trading near its 52-week low of $2.395 (13% above the low).
Summary
Quanterix reported Q2 revenue up 34% but missed expectations and slashed its full-year 2026 revenue guidance by about 15% to $142-148 million, citing execution challenges and market softness. Gross margin guidance was also cut, and cash flow breakeven is now pushed to 2027. The company is reorganizing its commercial teams and adding experienced leaders to address performance issues. This follows a series of executive changes, including a new CFO and COO appointed in recent months. The sharp guidance cut and delayed profitability timeline signal deeper operational struggles that will likely pressure the stock.
At the time of this announcement, QTRX was trading at $2.71 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $189.8M. The 52-week trading range was $2.40 to $8.77. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.